Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • Our Impact
    • Why CIFAR?
    • Impact Clusters
    • News
    • CIFAR Strategy
    • Nurturing a Resilient Earth
    • AI Impact
    • Donor Impact
    • CIFAR 40
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
    • Staff Directory
  • Support Us
  • About
    • Our Story
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
    • Statement on Institutional Neutrality
    • Research Security
  • fr
Announcement

CIFAR President and CEO Dr. Alan Bernstein to receive honorary degree from the University of Toronto

By: Jon Farrow
28 Feb, 2019
February 28, 2019
Alan Bernstein

The Doctor of Laws, honoris causa degree is the University’s highest honour and will be formally awarded in June.

Dr. Alan Bernstein, President and CEO of CIFAR, has been offered an honorary degree in recognition of his research excellence and his contributions to medicine, medical research, and education at the local, national and international levels.

In the award letter, Meric Gertler, president of the University of Toronto, writes that Dr. Bernstein’s “leadership of major Canadian and international research institutions, together with [his] efforts to promote innovative and collaborative research, have enriched the field of medicine.”

Dr. Bernstein, who received both his BSc and PhD from the University of Toronto, expressed his appreciation for the award. “I am truly honoured to be recognized in this way by the university where my career started. There has never been a time when young people, and research that crosses boundaries of discipline and country, have been more important than right now. As Canada’s most research-intensive university, U of T has a central role to play in addressing the global challenges of the 21st century.”

Dr. Bernstein became CIFAR’s President and CEO in May 2012. He was previously executive director of the Global HIV Vaccine Enterprise in New York, an international alliance of researchers and funders charged with accelerating the search for an HIV vaccine.

From 2000 to 2007, he served as the inaugural president of the Canadian Institutes of Health Research (CIHR), Canada’s federal agency for the support of health research. In that capacity, he led the transformation of health research in Canada.

After being confirmed today by the University’s Governing Council, Dr. Bernstein will be presented with the honorary degree at a convocation ceremony in June.

  • Follow Us

Related Articles

  • CIFAR researcher Carolina Tropini is appointed Alan Bernstein Fellow
    March 01, 2023
  • CIFAR at the Science Summit during the United Nations General Assembly
    November 02, 2022
  • President to President: in conversation with Alan Bernstein and Stephen Toope
    November 02, 2022
  • My Last Message as President and CEO of CIFAR
    October 31, 2022

Support Us

The Canadian Institute for Advanced Research (CIFAR) is a globally influential research organization proudly based in Canada. We mobilize the world’s most brilliant people across disciplines and at all career stages to advance transformative knowledge and solve humanity’s biggest problems, together. We are supported by the governments of Canada, Alberta and Québec, as well as Canadian and international foundations, individuals, corporations and partner organizations.

Donate Now
CIFAR footer logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2025 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

Fields marked with an * are required

Je préfère m’inscrire en français (cliquez ici).


Subscribe to our CIFAR newsletters: *

You can unsubscribe from these communications at any time. View our privacy policy.


As a subscriber you will also receive a digital copy of REACH, our annual magazine which highlights our researchers and their breakthroughs with long-form features, interviews and illustrations.


Please provide additional information if you would like to receive a print edition of REACH.


This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more

Notifications